Overview
Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects
Status:
Completed
Completed
Trial end date:
2006-08-01
2006-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is the first multiple-dose experience in humans with MOA-728 in an oral formulation. This study will provide an assessment of the safety, tolerability, and pharmacokinetics (PK) of MOA-728 following administration of ascending multiple oral doses to healthy subjects.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Criteria
Inclusion Criteria:- Healthy men and women